Vivos Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Vivos Therapeutics, Inc. (VVOS) reported Increase (Decrease) in Accrued Liabilities of $1.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $929.00K, a 187.62% increase year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $125.00K.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $3.30M, a 1200.39% increase year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $442.00K.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $3.62M.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$39.00K, a 109.24% decline from fiscal 2023.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $422.00K.
- Vivos Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$941.00K, a 184.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.05M 10-Q · filed 2026-08-14 | $4.36M derived: sum of 3 quarters · filed 2026-08-14 | $4.80M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-20 | $3.43M derived: sum of 2 quarters · filed 2026-05-20 | $3.87M derived: sum of 3 quarters · filed 2026-05-20 | $4.19M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $3.75M derived: sum of 2 quarters · filed 2026-04-15 | $4.07M derived: sum of 3 quarters · filed 2026-08-14 | $3.62M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $765.00K derived: sum of 2 quarters · filed 2026-08-14 | $315.00K 10-Q · filed 2025-11-19 | $569.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $323.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$127.00K 10-Q · filed 2026-08-14 | $127.00K derived: sum of 3 quarters · filed 2026-08-14 | $40.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$450.00K 10-Q · filed 2026-05-20 | -$196.00K derived: sum of 2 quarters · filed 2026-05-20 | -$283.00K derived: sum of 3 quarters · filed 2026-05-20 | -$621.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $167.00K derived: sum of 2 quarters · filed 2026-04-15 | -$171.00K derived: sum of 3 quarters · filed 2026-04-15 | -$39.00K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$425.00K derived: sum of 2 quarters · filed 2025-11-19 | -$293.00K 10-Q · filed 2025-11-19 | $87.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$206.00K 10-Q · filed 2025-08-19 | $174.00K derived: sum of 3 quarters · filed 2025-08-19 | $179.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $132.00K 10-Q · filed 2025-05-15 | $512.00K derived: sum of 2 quarters · filed 2025-05-15 | $517.00K derived: sum of 3 quarters · filed 2025-05-15 | $526.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $380.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $385.00K derived: sum of 2 quarters · filed 2025-03-31 | $394.00K derived: sum of 3 quarters · filed 2025-03-31 | $422.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $14.00K derived: sum of 2 quarters · filed 2024-11-14 | $42.00K 10-Q · filed 2024-11-14 | -$255.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $37.00K 10-Q · filed 2024-08-14 | -$260.00K derived: sum of 3 quarters · filed 2024-08-14 | -$798.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $28.00K 10-Q · filed 2024-05-14 | -$269.00K derived: sum of 2 quarters · filed 2024-07-30 | -$807.00K derived: sum of 3 quarters · filed 2024-07-30 | -$1.33M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | -$297.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | -$835.00K derived: sum of 2 quarters · filed 2024-07-30 | -$1.36M derived: sum of 3 quarters · filed 2024-07-30 | -$941.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | -$538.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.06M derived: sum of 2 quarters · filed 2023-11-14 | -$644.00K 10-Q · filed 2023-11-14 | -$324.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$106.00K 10-Q · filed 2023-08-16 | $214.00K derived: sum of 3 quarters · filed 2023-08-16 | $112.00K derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | $419.00K 10-Q · filed 2023-06-08 | $739.00K derived: sum of 2 quarters · filed 2023-06-08 | $637.00K derived: sum of 3 quarters · filed 2023-06-08 | $808.00K derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $218.00K derived: sum of 2 quarters · filed 2023-03-30 | $389.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.12M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $69.00K derived: sum of 2 quarters · filed 2022-12-20 | $797.00K 10-Q · filed 2022-12-20 | $796.57K 10-Q · filed 2021-11-15 | $288.49K derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | $171.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $899.00K 10-Q · filed 2022-12-20 | $899.20K 10-Q · filed 2021-08-12 | $390.49K derived: sum of 3 quarters · filed 2022-12-20 | $1.13M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | $728.00K 10-Q/A · filed 2022-11-25 | $727.56K 10-Q · filed 2021-05-17 | $219.49K derived: sum of 2 quarters · filed 2022-11-25 | $955.82K derived: sum of 3 quarters · filed 2022-11-25 | $553.02K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$508.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $227.82K derived: sum of 2 quarters · filed 2022-03-31 | -$174.98K derived: sum of 3 quarters · filed 2022-03-31 | $474.00K 10-K · filed 2022-03-31 | $473.97K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $736.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $333.53K derived: sum of 2 quarters · filed 2021-11-15 | $982.51K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$402.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $246.18K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $648.98K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $672.89K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |